Literature DB >> 12617727

The Surviving Sepsis Campaign: raising awareness to reduce mortality.

Elizabeth Slade, Pritpal S Tamber, Jean-Louis Vincent.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 12617727      PMCID: PMC154124          DOI: 10.1186/cc1876

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.

At the annual congress of the European Society of Intensive Care Medicine (ESICM) in October 2002, the newly formed Surviving Sepsis Campaign issued their 'Barcelona Declaration' – a call for action against sepsis, which is a leading cause of death in the intensive care unit (ICU). Surviving Sepsis aims to harness the support of governments, health agencies, the public and other health care professionals to decrease the relative mortality of sepsis by 25% over the next 5 years. The idea for the Campaign is based on the previous success of the so-called "Milan Declaration" made at a meeting of the European Association for the Study of Obesity, which helped raise awareness of the problems of obesity. A similar success is hoped for Surviving Sepsis, which is a collaborative project by three major intensive/critical care organisations: the European Society of Intensive Care Medicine (ESICM), the Society of Critical Care Medicine (SCCM), and the International Sepsis Forum (ISF). Although the initial funding for the Campaign was provided by an unrestricted educational grant from Eli Lilly and Company, both Baxter and Edwards Lifesciences are now contributors. The Campaign organisers also continue to seek funding from other commercial and non-commercial sources. The documented incidence of sepsis worldwide is 1.8 million each year, but this number is confounded by a low diagnostic rate and difficulties in tracking sepsis in many countries. Surviving Sepsis estimate that with an incidence of 3 in 1000 the true number of cases each year reaches 18 million, and with a mortality rate of almost 30% it becomes a leading cause of death worldwide [1,2]. The incidence is set to rise as the population ages, the elderly being worse affected [1]. Sepsis costs on average US$22 000 per patient, and its treatment therefore has a great impact on hospitals' financial resources, with US$16.7 billion each year being spent in the USA alone [1]. The cost of treating an ICU patient with sepsis is six times greater than that of treating a patient without sepsis [3]. The Campaign aims to raise awareness of the challenges associated with sepsis. The fundamental challenge is the difficulty in its diagnosis [4,5]. There is no consensus on the clinical definition of sepsis and, because of lack of training, intensivists often miss the diagnosis [6]; this is especially problematic, given that early treatment is associated with greater success [7]. Another challenge is that the cause of sepsis is often hard to pinpoint and therefore manage [8]. The incidence of sepsis is increasing, not just as a result of the aforementioned ageing population but also because of the development of resistance to antibiotics [9]. Even with successful treatment the effects of sepsis can be long lasting, with survivors having a significantly lower quality of life than before their illness [10].

What will Surviving Sepsis do?

The Barcelona Declaration outlined a six-point action plan (Table 1) aimed at improving the management of sepsis. The declaration – in essence a document outlining the problems associated with sepsis, a statement of intent and a call to action – recognizes the importance of increasing awareness of sepsis among health care professionals, governments, the public and funding bodies. Using the Declaration as a springboard, Surviving Sepsis is currently collaborating with national societies to find how countries manage sepsis, the challenges they encounter and how their hospital services are structured. From this they hope to create a policy document by the second quarter of 2003, which they will use to secure further sponsorship, particularly from governments and bodies such as the World Health Organization and the US National Institutes of Health. This sponsorship will fund the production of evidence-based guidelines on the management of sepsis, which Surviving Sepsis hopes to release at the annual congress of the ESICM in October 2003. These guidelines will reiterate the definition of sepsis given by the 'Washington paper' – which is yet to be published but has been described elsewhere [5] – and will be the first step toward a global strategy to combat sepsis that can be adapted to local use. In the meantime, the Surviving Sepsis Campaign is planning a presentation describing the public's awareness of sepsis, and a summary of the process of producing the guidelines on source control and management at the upcoming SCCM's Critical Care Congress in January 2003.
Table 1

Call to action: the Surviving Sepsis six-point action plan

IssueDetails
AwarenessIncrease awareness of health care professionals, governments, health and funding agencies, and the public of the high frequency and mortality associated with sepsis
DiagnosisImprove the early and accurate diagnosis of sepsis by developing a clear and clinically relevant definition of sepsis and disseminating it to our peers
TreatmentIncrease the use of appropriate treatments and interventions by disseminating the range of care options and urging their timely use
EducationEncourage the education of all health care professionals who manage sepsis patients by providing leadership, support and information to them about all aspects of sepsis management, including diagnosis, treatments and interventions, and standards of care
CounsellingProvide a framework for improving and accelerating access to post-ICU care and counselling for sepsis patients
ReferralRecognize the need for clear referral guidelines that are accepted and adopted at a local level in all countries by initiating the development of global guidelines

Data from Surviving Sepsis [6]. ICU, intensive care unit.

Call to action: the Surviving Sepsis six-point action plan Data from Surviving Sepsis [6]. ICU, intensive care unit. With the Barcelona Declaration, the evidence-based guidelines and the policy document describing practices in different countries, those involved in Surviving Sepsis hope that governments, health agencies, the public and health care professionals will support their campaign to tackle the challenges of sepsis.

Competing interests

None declared.

Abbreviations

ESICM = European Society of Intensive Care Medicine; ICU = intensive care unit; ISF = International Sepsis Forum; SCCM = Society of Critical Care Medicine.
  9 in total

1.  Managing antibiotic resistance.

Authors:  R P Wenzel; M B Edmond
Journal:  N Engl J Med       Date:  2000-12-28       Impact factor: 91.245

2.  Early goal-directed therapy in the treatment of severe sepsis and septic shock.

Authors:  E Rivers; B Nguyen; S Havstad; J Ressler; A Muzzin; B Knoblich; E Peterson; M Tomlanovich
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

3.  Age-adjusted death rates: trend data based on the year 2000 standard population.

Authors:  D L Hoyert; R N Anderson
Journal:  Natl Vital Stat Rep       Date:  2001-09-21

4.  Sepsis definitions.

Authors:  Jean-Louis Vincent
Journal:  Lancet Infect Dis       Date:  2002-03       Impact factor: 25.071

5.  Long-term health-related quality of life in survivors of sepsis. Short Form 36: a valid and reliable measure of health-related quality of life.

Authors:  D K Heyland; W Hopman; H Coo; J Tranmer; M A McColl
Journal:  Crit Care Med       Date:  2000-11       Impact factor: 7.598

Review 6.  Epidemiology of sepsis: an update.

Authors:  D C Angus; R S Wax
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

7.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

Review 8.  Treating patients with severe sepsis.

Authors:  A P Wheeler; G R Bernard
Journal:  N Engl J Med       Date:  1999-01-21       Impact factor: 91.245

9.  The patient-related costs of care for sepsis patients in a United Kingdom adult general intensive care unit.

Authors:  D L Edbrooke; C L Hibbert; J M Kingsley; S Smith; N M Bright; J M Quinn
Journal:  Crit Care Med       Date:  1999-09       Impact factor: 7.598

  9 in total
  57 in total

1.  Population burden of long-term survivorship after severe sepsis in older Americans.

Authors:  Theodore J Iwashyna; Colin R Cooke; Hannah Wunsch; Jeremy M Kahn
Journal:  J Am Geriatr Soc       Date:  2012-05-29       Impact factor: 5.562

2.  New arrhythmias after non-cardiothoracic surgery.

Authors:  Stewart R Walsh; Tjun Tang; Michael E Gaunt; Hank J Schneider
Journal:  BMJ       Date:  2006-10-07

3.  The European Society of Intensive Care Medicine (ESICM) and the Surviving Sepsis Campaign (SSC).

Authors:  V Marco Ranieri; Rui P Moreno; Andy Rhodes
Journal:  Intensive Care Med       Date:  2007-02-16       Impact factor: 17.440

4.  The uncovering of ESE-1 in human neutrophils: implication of its role in neutrophil function and survival.

Authors:  C M Lee; S Gupta; J Parodo; J Wu; J C Marshall; J Hu
Journal:  Genes Immun       Date:  2015-04-23       Impact factor: 2.676

5.  Randomized controlled trials and practice guidelines: the good, the bad, and the ugly.

Authors:  Charles L Sprung
Journal:  Intensive Care Med       Date:  2012-10-12       Impact factor: 17.440

6.  The Knowledge of the Physicians about Sepsis Bundles is Suboptimal: A Multicenter Survey.

Authors:  Zeliha Kocak Tufan; Fatma Civelek Eser; Emre Vudali; Ayse Batirel; Bircan Kayaaslan; Aliye Tanrici Bastug; Deniz Eray; Vedat Turhan; Fazilet Duygu; Duran Tok; Serife Altun; Cemal Bulut; Mehmet A Tasyaran
Journal:  J Clin Diagn Res       Date:  2015-07-01

7.  Construction and management of ARDS/sepsis registry with REDCap.

Authors:  Xiaoqing Pang; Natascha Kozlowski; Sulong Wu; Mei Jiang; Yongbo Huang; Pu Mao; Xiaoqing Liu; Weiqun He; Chaoyi Huang; Yimin Li; Haibo Zhang
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

8.  Granzyme K synergistically potentiates LPS-induced cytokine responses in human monocytes.

Authors:  Annette C Wensink; Vera Kemp; Job Fermie; M Isabel García Laorden; Tom van der Poll; C Erik Hack; Niels Bovenschen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-07       Impact factor: 11.205

9.  Trends in hospitalizations of patients with sepsis and factors associated with inpatient mortality in the Region of Madrid, 2003–2011.

Authors:  O H Ayala-Ramírez; M F Domínguez-Berjón; M D Esteban-Vasallo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03       Impact factor: 3.267

10.  Volatile anesthetics improve survival after cecal ligation and puncture.

Authors:  Inge K Herrmann; Maricela Castellon; David E Schwartz; Melanie Hasler; Martin Urner; Guochang Hu; Richard D Minshall; Beatrice Beck-Schimmer
Journal:  Anesthesiology       Date:  2013-10       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.